GemPharmatech Co., Ltd.

SHSE:688046 Stock Report

Market Cap: CN¥5.3b

GemPharmatech Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jing Zhao

Chief executive officer

CN¥859.0k

Total compensation

CEO salary percentagen/a
CEO tenure7yrs
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

An Intrinsic Calculation For GemPharmatech Co., Ltd. (SHSE:688046) Suggests It's 44% Undervalued

Dec 05
An Intrinsic Calculation For GemPharmatech Co., Ltd. (SHSE:688046) Suggests It's 44% Undervalued

GemPharmatech's (SHSE:688046) Problems Go Beyond Weak Profit

Sep 10
GemPharmatech's (SHSE:688046) Problems Go Beyond Weak Profit

GemPharmatech (SHSE:688046) Seems To Use Debt Quite Sensibly

Jul 22
GemPharmatech (SHSE:688046) Seems To Use Debt Quite Sensibly

Some GemPharmatech Co., Ltd. (SHSE:688046) Shareholders Look For Exit As Shares Take 29% Pounding

Apr 16
Some GemPharmatech Co., Ltd. (SHSE:688046) Shareholders Look For Exit As Shares Take 29% Pounding

CEO

Jing Zhao (43 yo)

7yrs

Tenure

CN¥859,000

Compensation

Dr. Jing Zhao is CEO at GemPharmatech Co., Ltd. and has been its GM and Director since January 2018 and was its Secretary. She has experience in animal model creation and analysis.She is currently the Dep...

Leadership Team

NamePositionTenureCompensationOwnership
Jing Zhao
GM & Director7yrsCN¥859.00kno data
Chongbo Xu
Chief Financial Officer1.3yrsCN¥1.06mno data
Zhongyu Li
Deputy GM & Director6.1yrsCN¥823.70kno data
Tao Wang
Deputy GM & Director1.8yrsCN¥657.10kno data
Yiou Wang
Board Secretary1.8yrsCN¥975.00kno data
Hong-Yu Wang
Chief Technology Officerno datano datano data
Hongyan Sun
Deputy Director of Functional Pharmacodynamics Centerno datano datano data

1.8yrs

Average Tenure

40yo

Average Age

Experienced Management: 688046's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jing Zhao
GM & Director7yrsCN¥859.00kno data
Zhongyu Li
Deputy GM & Director7.1yrsCN¥823.70kno data
Tao Wang
Deputy GM & Director1.6yrsCN¥657.10kno data
Minmin Yang
Director1.3yrsno datano data
Derong Leng
Director1.3yrsno datano data
Bo Yu
Independent Director4.3yrsCN¥100.00kno data
Bin-Qing Xiao
Independent Director4.3yrsCN¥100.00kno data
Xiang Gao
Chairman of the Board7.1yrsCN¥1.91mno data
Juan Du
Independent Director4.3yrsCN¥100.00kno data
Tao Wen
Supervisor4.3yrsno datano data
Cunxiang Ju
Chairman of the Board of Supervisors15.3yrsno datano data
Huixin Yang
Employee Representative Supervisor4.3yrsno datano data

4.3yrs

Average Tenure

45yo

Average Age

Experienced Board: 688046's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 02:43
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GemPharmatech Co., Ltd. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.
Kai WangCitic Securities Co., Ltd.
Yiling ChenGuosen Securities Co., Ltd.